PLASMA News & Analysis

And Morningstar analyst Nicolette Quinn has tempered her forecasts for sales of immunoglobulins.

Fisher & Paykel’s share price has soared as COVID-19 cases rise in Australia, US and Europe, while CSL’s latest acquisition marks...

The biotech giant has jumped 22pc a year for the past decade but new players are emerging.